Warner Bros. Discovery, Inc.
AZAINDOLE PYRAZOLE COMPOUNDS AS CDK9 INHIBITORS
Last updated:
Abstract:
The present invention discloses new azaindole pyrazole compounds as CDK9 inhibitors, in particular, compounds as represented by formula (I), pharmaceutically acceptable salts and isomers thereof, and the use of compounds represented by formula (I), pharmaceutically acceptable salts and isomers thereof, and the pharmaceutical composition containing them in the preparation of cancer drugs. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
24 Jun 2020
Issue date:
25 Aug 2022